Aim for the brain: RA Cap­i­tal bets on Col­orado biotech to re­for­mu­late epilep­sy drug for re­frac­to­ry pa­tients

A decades-old an­ti-epilep­tic drug, linked to de­for­mi­ties in un­born chil­dren, is be­ing re­for­mu­lat­ed for in­jec­tion straight in­to the brain of pa­tients whose epilep­sy has per­sist­ed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER